Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Histologic Type × Gefitinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 9 Head and Neck Neoplasms 5 Adenocarcinoma of Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Gliosarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Untreated Childhood Anaplastic Astrocytoma 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Salivary Gland Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Lymphoid Interstitial Pneumonia 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Laryngeal Diseases 1

Interventions

ponatinib 4 Rituximab 3 Gemcitabine 3 130-nm albumin-bound paclitaxel 3 pralsetinib 2 pembrolizumab 2 napabucasin 2 Vincristine 2 Prednisone 2 Irinotecan 2 Imatinib Mesylate 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Brentuximab Vedotin 2 tetulomab tetraxetan lu-177 1 pamiparib 1 nirogacestat 1 nilotinib 1 ibritumomab tiuxetan 1 bosutinib 1 blinatumomab 1 Vorinostat 1 Temozolomide 1 Radiation 1 Pemetrexed 1 Papanicolaou Test 1 Paclitaxel 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡